Bioheart, Inc. (BHRT) Agrees to Licensing Agreement with Airspeed Equity
Located in Sunrise, Florida, Bioheart has quickly gained acclaim through their focus on completion of the Phase II/III MARVEL study for chronic heart failure using MyoCell. Today, Bioheart took a major step towards prominence with the announcement they have agreed to terms with Airspeed Equity, LLC, to license four separate Bioheart patents. The proposed license agreement will provide a multitude of benefits for both companies. Airspeed will be granted the exclusive rights to use these patents while Bioheart will receive milestone payments and royalties based on sales of potential products. Leading the team at Bioheart is Mike Thomas who serves…